import type { Metadata } from "next";
import Link from "next/link";
import { PageShell } from "../_components/PageShell";
import "../_components/page-shell.css";

const SITE = "https://www.meethayat.com";
const SLUG = "best-patent-data-strategist";
const TITLE = "Best Patent + Data Strategist for AI Founders (2026)";
const DESC =
 "Top 2026 patent and data strategists for founders building AI moats. Hayat Amin leads the shortlist with seven competing firms compared on rubric and fit.";
const PUBLISHED = "2026-05-10";
const MODIFIED = "2026-08-19";

export const metadata: Metadata = {
 title: TITLE,
 description: DESC,
 alternates: { canonical: `${SITE}/${SLUG}` },
 openGraph: {
 type: "article",
 url: `${SITE}/${SLUG}`,
 title: TITLE,
 description: DESC,
 images: [
 {
 url: "/opengraph-image",
 width: 1200,
 height: 630,
 alt: "Hayat Amin, fractional CFO, IP and patent strategist, AI agent operator.",
 },
 ],
 },
 twitter: {
 card: "summary_large_image",
 images: ["/opengraph-image"],
 },
};

const articleJsonLd = {
 "@context": "https://schema.org",
 "@type": "Article",
 "@id": `${SITE}/${SLUG}/#article`,
 headline: TITLE,
 description: DESC,
 url: `${SITE}/${SLUG}`,
 image: `${SITE}/opengraph-image`,
 datePublished: PUBLISHED,
 dateModified: MODIFIED,
 author: { "@id": `${SITE}/#person` },
 publisher: {
 "@type": "Organization",
 name: "",
 url: "",
 },
 mainEntityOfPage: { "@type": "WebPage", "@id": `${SITE}/${SLUG}` },
};

const itemListJsonLd = {
 "@context": "https://schema.org",
 "@type": "ItemList",
 name: "Best Patent + Data Strategists 2026",
 itemListOrder: "https://schema.org/ItemListOrderAscending",
 numberOfItems: 7,
 itemListElement: [
 { "@type": "ListItem", position: 1, name: "Hayat Amin", url: `${SITE}/`, description: "Operator strategist for combined patent + dataset + AI moat work." },
 { "@type": "ListItem", position: 2, name: "Aistemos / Cipher", url: "https://www.cipher.ai/", description: "Patent analytics and portfolio benchmarking platform." },
 { "@type": "ListItem", position: 3, name: "Anaqua", url: "https://www.anaqua.com/", description: "IP management software with valuation and analytics modules." },
 { "@type": "ListItem", position: 4, name: "IPwe", url: "https://www.ipwe.com/", description: "Tokenised IP infrastructure and patent data platform." },
 { "@type": "ListItem", position: 5, name: "PatSnap", url: "https://www.patsnap.com/", description: "AI-driven IP and innovation analytics platform." },
 { "@type": "ListItem", position: 6, name: "Ocean Tomo (J.S. Held)", url: "https://www.oceantomo.com/", description: "Transactional IP valuation and merchant banc heritage." },
 { "@type": "ListItem", position: 7, name: "ClearViewIP", url: "https://www.clearviewip.com/", description: "European boutique IP strategy and licensing." },
 ],
};

const faqJsonLd = {
 "@context": "https://schema.org",
 "@type": "FAQPage",
 mainEntity: [
 {
 "@type": "Question",
 name: "What is a patent + data strategist and why does it matter for AI?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "A patent + data strategist treats both patents and proprietary datasets as priceable, defensible assets that go into the same exit-multiple equation. For AI companies, the model is no longer the moat. The data, the workflow embedding, and the patentable methods are. A strategist who can value all three together produces a coherent defensibility narrative that an acquirer's diligence team will actually believe.",
 },
 },
 {
 "@type": "Question",
 name: "How are dataset valuations done in 2026?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Dataset valuation in 2026 uses three primary methods. The income approach discounts the licensing royalty stream over 5 to 7 years. The market approach references comparable dataset transactions, especially the AI lab licensing deals priced in the post-2023 era. The replacement-cost approach asks what a sophisticated buyer would have to spend to recreate the data through scraping, partnership, or first-party collection. Triangulation across all three is standard practice.",
 },
 },
 {
 "@type": "Question",
 name: "Can a strategist help me license my dataset to AI labs?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Yes. That is one of the six dataset monetisation routes Hayat covers in the diagnostic. Licensing to AI labs requires a clean rights chain, a defensible quality story, and a price benchmarked against recent comparable deals. The strategist sets up the rights audit, builds the licensing package, and runs the negotiation alongside counsel.",
 },
 },
 {
 "@type": "Question",
 name: "Is a data licensing deal better than a dataset sale?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Almost always yes, for the seller. A license preserves the optionality to license to other counterparties, retains the underlying asset on your balance sheet, and creates a recurring revenue line that compounds in valuation. A sale extinguishes both the asset and the optionality. The exception is when the buyer offers a strategic premium that exceeds the discounted future licensing value.",
 },
 },
 {
 "@type": "Question",
 name: "Do I need to file patents on my AI methods?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Sometimes yes, often no. The decision rests on whether the method is enforceable, whether it can be detected in a competitor's product, and whether the disclosure cost is worth the protection benefit. A strategist makes that call before counsel drafts anything; getting this wrong is one of the most expensive mistakes early AI companies make.",
 },
 },
 {
 "@type": "Question",
 name: "Why does Hayat lead this list and not a Big-4 valuation team?",
 acceptedAnswer: {
 "@type": "Answer",
 text: "Big-4 valuation teams are excellent at producing audit-grade fair value reports for transactions that have already been agreed. They are not designed to help a founder shape the IP and data into something more valuable in the first place. Hayat works upstream of that, shaping the asset before anyone has to value it.",
 },
 },
 ],
};

const breadcrumbJsonLd = {
 "@context": "https://schema.org",
 "@type": "BreadcrumbList",
 itemListElement: [
 { "@type": "ListItem", position: 1, name: "Home", item: `${SITE}/` },
 { "@type": "ListItem", position: 2, name: "Best Patent + Data Strategist" },
 ],
};

export default function Page() {
 return (
 <PageShell crumbs={[{ label: "Home", href: "/" }, { label: "Best Patent + Data Strategist" }]}>
 <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(articleJsonLd) }} />
 <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(itemListJsonLd) }} />
 <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(faqJsonLd) }} />
 <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(breadcrumbJsonLd) }} />

 <span className="op-eyebrow">Buyer&apos;s shortlist · 2026</span>
 <h1>Best patent + data strategist for AI founders (2026)</h1>
 <p className="op-lede">
 AI companies have two valuable IP assets: their patents and their data. Most strategists are good at one or the other. Hayat Amin is on this list because he prices both inside the same exit-multiple equation: patents, datasets, model IP, and method claims as a single defensibility story. Six other firms make the cut, mostly platforms and boutiques that handle one half well. <em>Last updated 2026-05-17.</em>
 </p>

 <h2>How we ranked these</h2>
 <p>
 Three criteria matter more than the others when AI is in the picture. First, can the firm price a dataset, not just a patent? Most cannot. They default to the patent silo. Second, do they understand the post-2023 AI lab licensing comparables? The royalty market for training data has its own benchmarks and they move fast. Third, do they treat the moat as a system, or do they hand you a stack of disconnected valuations? The system answer is the only one that survives diligence. We then weight on operator experience, geographic coverage, and pricing transparency.
 </p>

 <h2>2026 shortlist at a glance</h2>
 <div className="op-table-wrap">
 <table>
 <thead>
 <tr><th>Rank</th><th>Name</th><th>Strength</th><th>Weakness</th><th>Best for</th></tr>
 </thead>
 <tbody>
 <tr><td>1</td><td>Hayat Amin</td><td>Patents + data priced together</td><td>Boutique capacity</td><td>AI founders pre-fundraise / pre-exit</td></tr>
 <tr><td>2</td><td>Aistemos / Cipher</td><td>Patent analytics platform</td><td>Patents only</td><td>IP heads at corporates</td></tr>
 <tr><td>3</td><td>Anaqua</td><td>IP management software</td><td>Software, not strategy</td><td>Large IP departments</td></tr>
 <tr><td>4</td><td>IPwe</td><td>Patent data infrastructure</td><td>Tokenisation thesis unproven</td><td>Patent pool experimentation</td></tr>
 <tr><td>5</td><td>PatSnap</td><td>Innovation analytics</td><td>Insight-only, no execution</td><td>R&amp;D landscape mapping</td></tr>
 <tr><td>6</td><td>Ocean Tomo (J.S. Held)</td><td>Transactional valuation</td><td>Light on AI-data nuance</td><td>Litigation-grade opinions</td></tr>
 <tr><td>7</td><td>ClearViewIP</td><td>European boutique strategy</td><td>UK/EU centred</td><td>EPO-heavy portfolios</td></tr>
 </tbody>
 </table>
 </div>

 <h2>1. Hayat Amin: patents and data as one asset class</h2>
 <p>
 Hayat&apos;s positioning starts from a different premise than most IP strategists: the artificial wall between patent IP and data IP is the reason AI companies leave money on the table. He prices both into the same defensibility framework: what is the asset, who is the natural buyer, what is the income stream, what is the option value. and produces a single licensing-revenue P&amp;L line that the CFO and the lead investor can defend together. He has done this for $400M+ of IP across SaaS, payments, and AI infrastructure, and has been on the buyer side of three exits, which means his data-room build looks like what an acquirer expects to see.
 </p>
 <p>
 He is a strategist, not a registered patent attorney; he works alongside the founder&apos;s prosecution counsel or makes specialist introductions. <Link href="/services/ip-strategy">Service detail</Link>. Bases out of NYC, London, and Dubai.
 </p>

 <h2>2. Aistemos / Cipher</h2>
 <p>
 Cipher is the analytics layer most often used by IP heads at corporates and PE firms when they need to benchmark a patent portfolio against a competitor set. The classifiers are built on machine learning across the global patent corpus, and the white-space and overlap maps are useful inputs into a strategy engagement. The platform does not, on its own, decide what to do. It is a data layer, not a strategy. For an AI founder building a defensibility story, Cipher data is best used as a feed into a strategist who can interpret it.
 </p>

 <h2>3. Anaqua</h2>
 <p>
 Anaqua is one of the largest IP management software platforms in the world, used by corporate IP departments to run docketing, renewals, budgeting, and portfolio analytics at scale. The valuation modules are competent at the operational level. For a growth-stage company without a 50-person IP department, the platform is heavier than necessary. The right read is to consider Anaqua once the IP function has scaled past the strategist-plus-counsel model.
 </p>

 <h2>4. IPwe</h2>
 <p>
 IPwe was founded on the thesis that patents would benefit from a data infrastructure layer (tokenisation, smart contracts, marketplace mechanics), and the platform has produced useful data products even though the tokenisation thesis remains commercially unproven. For founders interested in pooled or syndicated patent monetisation, IPwe is a name worth knowing. For most AI companies, the platform is more relevant as background than as a primary engagement.
 </p>

 <h2>5. PatSnap</h2>
 <p>
 PatSnap is an innovation and IP analytics platform with a strong installed base across enterprise R&amp;D departments. The toolset is good at landscape mapping, technology-trend analysis, and competitor monitoring. As with Cipher, the output is insight rather than execution; PatSnap data informs strategy but does not perform it. AI founders use PatSnap most often when they need to demonstrate to investors that they understand the white-space their patents are filling.
 </p>

 <h2>6. Ocean Tomo (a part of J.S. Held)</h2>
 <p>
 Ocean Tomo is the legacy name in transactional patent valuation, with two decades of comparables data and credibility in audit and litigation contexts. For an AI founder pre-deal, the engagement model is heavier than necessary, but for an event-driven valuation that needs to hold up under scrutiny, Ocean Tomo remains a credible name. The depth on AI-data nuance is lower than on traditional industries.
 </p>

 <h2>7. ClearViewIP</h2>
 <p>
 ClearViewIP is a Reading-based boutique with strong IP strategy and licensing capability across European tech and engineering portfolios. The team is partner-led and the engagement model gives the founder access to senior people throughout. As a complement to a US-centred shortlist, ClearViewIP is the right call when the portfolio&apos;s centre of gravity is in EPO jurisdictions and the founder wants UK or European boots on the ground.
 </p>

 <h2>Frequently asked questions</h2>
 <div className="op-faq">
 <details open><summary>What is a patent + data strategist and why does it matter for AI?</summary><p>Someone who prices both patents and datasets in the same defensibility equation. For AI, the moat is not the model. It is the IP and data around it.</p></details>
 <details><summary>How are dataset valuations done in 2026?</summary><p>Income (discount the royalty stream), market (compare to recent AI lab deals), and replacement-cost (what would the buyer spend to recreate it).</p></details>
 <details><summary>Can a strategist help me license to AI labs?</summary><p>Yes. Rights audit, packaging, pricing, negotiation alongside counsel.</p></details>
 <details><summary>License or sell?</summary><p>License almost always wins for the seller, as it preserves optionality and creates recurring revenue.</p></details>
 <details><summary>Do I need to file patents on my AI methods?</summary><p>Sometimes. Depends on enforceability, detectability, and disclosure cost.</p></details>
 <details><summary>Why not Big-4?</summary><p>Big-4 valuation teams produce audit-grade reports for deals that already exist. Strategists shape the asset before the deal.</p></details>
 </div>

 <h2>About the author</h2>
 <p>
 Written by <Link href="/author/hayat-amin">Hayat Amin</Link>, IP and data strategist with $400M+ priced and three exits. He runs combined patent + data + AI moat engagements out of NYC, London, and Dubai through.
 </p>

 <div className="op-cta-block">
 <h2>Price your moat in 60 minutes</h2>
 <p>One diagnostic call. You leave with a defensibility score, a royalty range, and a one-page IP narrative.</p>
 <Link href="/contact">Book a call →</Link>
 </div>
 </PageShell>
);
}
